title: Recurrent pregnancy loss: a disease of inflammation and coagulation.
abstract: Recurrent pregnancy loss (RPL) is one of the most common obstetrical complications. Multiple etiologies, such as endocrine, anatomic, genetic, hematological and immunological causes have been reported for this devastating disease. However, over half of the cases remain unexplained. Thrombotic/inflammatory processes are often observed at the maternal-fetal interface as the final pathological assault in many cases of RPL, including those of unexplained etiologies. In the present paper, cellular immune responses (T, natural killer [NK], natural killer-T [NKT], regulatory T [Treg] cells and their cytokines) and autoimmune abnormalities of women with RPL are reviewed. In addition, metabolic diseases and hematological conditions which often lead to thrombotic/inflammatory conditions are discussed in association with RPL. Finally, current therapeutic options for RPL are reviewed.
authors.affiliation: Departments of Obstetrics and Gynecology, Rosalind Franklin University of Medicine and Science/The Chicago Medical School, North Chicago, IL, USA. Joanne.kwak-kim@rosalindfranklin.edu
authors.forename: Joanne
authors.initials: J
authors.lastname: Kwak-Kim
authors.forename: Kwang Moon
authors.initials: KM
authors.lastname: Yang
authors.forename: Alice
authors.initials: A
authors.lastname: Gilman-Sachs
mesh_terms: D000026:Abortion, Habitual / Q000209:etiology* / Q000276:immunology; D001327:Autoimmune Diseases / Q000150:complications; D001778:Blood Coagulation Disorders / Q000209:etiology*; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007249:Inflammation / Q000209:etiology*; D008659:Metabolic Diseases / Q000150:complications; D011247:Pregnancy; D013601:T-Lymphocytes / Q000502:physiology
chemical_list: D006495:Heparin, Low-Molecular-Weight; D016756:Immunoglobulins, Intravenous